Mitchell McLeod Pugh & Williams’s CME Group CME Stock Holding History

Mitchell McLeod Pugh & Williams’s Portfolio CME Stock Details CME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$615K	Buy	2,783 +3	+0.1%	+$830	0.08%	190
2026 Q1	$821K	Buy	2,780 +25	+0.9%	+$7.43K	0.12%	146
2025 Q4	$833K	Hold	2,755	–	–	0.12%	143
2025 Q3	$734K	Sell	2,755 -400	-13%	-$109K	0.12%	144
2025 Q2	$870K	Buy	3,155 +350	+12%	+$95.2K	0.16%	128
2025 Q1	$744K	Hold	2,805	–	–	0.15%	136
2024 Q4	$651K	Hold	2,805	–	–	0.14%	142
2024 Q3	$619K	Hold	2,805	–	–	0.13%	151
2024 Q2	$551K	Buy	2,805 +3	+0.1%	+$620	0.13%	152
2024 Q1	$603K	Sell	2,802 -3	-0.1%	-$630	0.15%	149
2023 Q4	$591K	Sell	2,805 -2	-0.1%	-$427	0.16%	143
2023 Q3	$562K	Buy	2,807 +2	+0.1%	+$398	0.17%	142
2023 Q2	$520K	Hold	2,805	–	–	0.15%	144
2023 Q1	$537K	Buy	2,805 +105	+4%	+$19K	0.17%	140
2022 Q4	$454K	Buy	2,700 +310	+13%	+$53.9K	0.15%	152
2022 Q3	$423K	Buy	2,390 +36	+2%	+$7.12K	0.16%	143
2022 Q2	$482K	Hold	2,354	–	–	0.19%	134
2022 Q1	$560K	Sell	2,354 -155	-6%	-$36.4K	0.19%	134
2021 Q4	$573K	Sell	2,509 -220	-8%	-$48.4K	0.19%	131
2021 Q3	$528K	Hold	2,729	–	–	0.2%	131
2021 Q2	$580K	Buy	2,729 +31	+1%	+$6.54K	0.22%	123
2021 Q1	$551K	Sell	2,698 -8	-0.3%	-$1.58K	0.23%	121
2020 Q4	$493K	Hold	2,706	–	–	0.23%	120
2020 Q3	$453K	Buy	2,706 +155	+6%	+$26.1K	0.23%	125
2020 Q2	$415K	Hold	2,551	–	–	0.24%	122
2020 Q1	$441K	Hold	2,551	–	–	0.34%	102
2019 Q4	$512K	Hold	2,551	–	–	0.32%	111
2019 Q3	$539K	Buy	2,551 +3	+0.1%	+$627	0.37%	98
2019 Q2	$495K	Buy	2,548 +8	+0.3%	+$1.48K	0.34%	105
2019 Q1	$418K	Sell	2,540 -720	-22%	-$127K	0.29%	118
2018 Q4	$613K	Sell	3,260 -24	-0.7%	-$4.43K	0.49%	76
2018 Q3	$559K	Sell	3,284 -1,893	-37%	-$319K	0.38%	94
2018 Q2	$849K	Sell	5,177 -320	-6%	-$52.3K	0.6%	54
2018 Q1	$889K	Sell	5,497 -960	-15%	-$153K	0.64%	50
2017 Q4	$943K	Hold	6,457	–	–	0.65%	47
2017 Q3	$876K	Hold	6,457	–	–	0.65%	53
2017 Q2	$809K	Hold	6,457	–	–	0.61%	62
2017 Q1	$767K	Hold	6,457	–	–	0.6%	64
2016 Q4	$745K	Sell	6,457 -400	-6%	-$44.5K	0.6%	60
2016 Q3	$717K	Hold	6,857	–	–	0.63%	58
2016 Q2	$668K	Hold	6,857	–	–	0.6%	61
2016 Q1	$659K	Hold	6,857	–	–	0.64%	57
2015 Q4	$621K	Hold	6,857	–	–	0.62%	58
2015 Q3	$636K	Hold	6,857	–	–	0.66%	56
2015 Q2	$638K	Hold	6,857	–	–	0.59%	61
2015 Q1	$649K	Hold	6,857	–	–	0.59%	62
2014 Q4	$608K	Buy	+6,857	New	+$581K	0.56%	64

Other funds holding CME

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Mitchell McLeod Pugh & Williams's CME Position: Q2 2026 in Review

Mitchell McLeod Pugh & Williams increased its CME Group (CME) stake by 0.11% in Q2 2026, buying an estimated $830 and bringing the position to 2,783 shares worth $615K. The position accounts for 0.08% of the portfolio, ranked #190.

Mitchell McLeod Pugh & Williams first reported a position in CME in Q4 2014 and has held it in 47 quarters since. The position peaked at $943K in Q4 2017. 1,698 funds tracked by Wall St. Rank hold CME as of Q2 2026.

Mitchell McLeod Pugh & Williams held 2,783 shares of CME Group worth $615K as of Q2 2026.
Mitchell McLeod Pugh & Williams bought 3 CME Group shares in Q2 2026, an estimated $830.
CME Group made up 0.08% of Mitchell McLeod Pugh & Williams's portfolio in Q2 2026, its #190 holding.
Mitchell McLeod Pugh & Williams first reported a position in CME Group in Q4 2014 and has held it in 47 quarters since.
Mitchell McLeod Pugh & Williams's CME Group position peaked at $943K in Q4 2017.
1,698 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Mitchell McLeod Pugh & Williams's 13F filing for Q2 2026, filed 11 Aug 2026.